News

Eli Lilly Stock Gets a Double Downgrade. Where Weight-Loss Drugs Go From Here.
The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...
Zacks Investment Research on MSN20h
Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)
Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...
ISRG, LLY, or DXCM: Which “Strong Buy” Healthcare Stock Has the Highest Upside Potential?
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
STAT3h
The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position
With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...
The Agonizing Task of Turning Europe’s Power Back On
A massive blackout affecting Spain, Portugal, and parts of France has been blamed on atmospheric conditions. Now engineers ...
pharmaphorum12h
Lilly ends ADA on a high as obesity triple data pops
The first reveal of clinical data with Eli Lilly’s injectable ... targets GIP and GLP-1 – the same as Lilly’s fast-growing diabetes therapy Mounjaro (tirzepatide) – but adds in activity ...